Study Summary
This trialwill investigate the effectiveness of 4 ATSs to treat suicidal college students at CCCs. 700 participants ages 18-25 will receive either CAMS or TAU in Stage 1 and then be re-randomized to either CAMS or DBT in Stage 2.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
9 Primary · 0 Secondary · Reporting Duration: To 6 month follow-up
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
6 Treatment Groups
1
1 of 6
2
1 of 6
3
1 of 6
4
1 of 6
5
1 of 6
6
1 of 6
Experimental Treatment
700 Total Participants · 6 Treatment Groups
Primary Treatment: 1 · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 25 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this study open to senior citizens for participation?
"This clinical trial is open to participants aged 18 and above, but not exceeding 25 years old." - Anonymous Online Contributor
Are there any vacancies left for prospective participants of this research?
"As indicated on Clinicaltrials.gov, this research is currently recruiting participants; the trial was initially posted and last edited on October 25th 2022." - Anonymous Online Contributor
Am I eligible to take part in this research project?
"Patients within the age bracket of 18 to 25 who have attempted suicide are eligible for this study. A maximum of 700 individuals will be accepted into the trial." - Anonymous Online Contributor
Are there a plethora of sites in this locale where the examination is taking place?
"Rutgers University in New Brunswick, Duke University in Durham and the Univeristy of Nevada - Reno are amongst the 4 medical sites actively recruiting for this trial. There is also with additional locations offering enrollment opportunities." - Anonymous Online Contributor
What is the magnitude of enrollment for this medical experiment?
"Yes, according to clinicaltrials.gov this medical study is actively seeking participants. It was initially posted on October 25th 2022 and the information has since been updated. The trial plans to enlist 700 patients from 4 different locations across the country." - Anonymous Online Contributor